214 related articles for article (PubMed ID: 36309482)
1. Bromodomain-containing protein 4 (BRD4) as an epigenetic regulator of fatty acid metabolism genes and ferroptosis.
Yang M; Liu K; Chen P; Zhu H; Wang J; Huang J
Cell Death Dis; 2022 Oct; 13(10):912. PubMed ID: 36309482
[TBL] [Abstract][Full Text] [Related]
2. The BRD4-SRPK2-SRSF2 signal modulates the splicing efficiency of ACSL3 pre-mRNA and influences erastin-induced ferroptosis in osteosarcoma cells.
Luo SH; Tian JM; Chu Y; Zhu HY; Ni JD; Huang J
Cell Death Dis; 2023 Nov; 14(11):760. PubMed ID: 37993451
[TBL] [Abstract][Full Text] [Related]
3. Bromodomain-containing protein 4 regulates a cascade of lipid-accumulation-related genes at the transcriptional level in the 3T3-L1 white adipocyte-like cell line.
Mochizuki K; Yamada M; Inoue T; Hariya N; Kubota T; Goda T
Eur J Pharmacol; 2020 Sep; 883():173351. PubMed ID: 32650006
[TBL] [Abstract][Full Text] [Related]
4. Epigenetic Reader BRD4 (Bromodomain-Containing Protein 4) Governs Nucleus-Encoded Mitochondrial Transcriptome to Regulate Cardiac Function.
Kim SY; Zhang X; Schiattarella GG; Altamirano F; Ramos TAR; French KM; Jiang N; Szweda PA; Evers BM; May HI; Luo X; Li H; Szweda LI; Maracaja-Coutinho V; Lavandero S; Gillette TG; Hill JA
Circulation; 2020 Dec; 142(24):2356-2370. PubMed ID: 33113340
[TBL] [Abstract][Full Text] [Related]
5. BRD4 inhibitors broadly promote erastin-induced ferroptosis in different cell lines by targeting ROS and FSP1.
Fan C; Guo X; Zhang J; Zheng W; Shi C; Qin Y; Shen H; Lu Y; Fan Y; Li Y; Chen L; Mao R
Discov Oncol; 2024 Apr; 15(1):98. PubMed ID: 38565708
[TBL] [Abstract][Full Text] [Related]
6. Ferritinophagy is required for the induction of ferroptosis by the bromodomain protein BRD4 inhibitor (+)-JQ1 in cancer cells.
Sui S; Zhang J; Xu S; Wang Q; Wang P; Pang D
Cell Death Dis; 2019 Apr; 10(5):331. PubMed ID: 30988278
[TBL] [Abstract][Full Text] [Related]
7. p113 isoform encoded by CUX1 circular RNA drives tumor progression via facilitating ZRF1/BRD4 transactivation.
Yang F; Hu A; Guo Y; Wang J; Li D; Wang X; Jin S; Yuan B; Cai S; Zhou Y; Li Q; Chen G; Gao H; Zheng L; Tong Q
Mol Cancer; 2021 Sep; 20(1):123. PubMed ID: 34579723
[TBL] [Abstract][Full Text] [Related]
8. Epigenetic Reader Bromodomain-Containing Protein 4 in Aging-Related Vascular Pathologies and Diseases: Molecular Basis, Functional Relevance, and Clinical Potential.
Zheng X; Diktonaite K; Qiu H
Biomolecules; 2023 Jul; 13(7):. PubMed ID: 37509171
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of cannabinoid receptor type 1 sensitizes triple-negative breast cancer cells to ferroptosis via regulating fatty acid metabolism.
Li P; Lin Q; Sun S; Yang N; Xia Y; Cao S; Zhang W; Li Q; Guo H; Zhu M; Wang Y; Zheng Z; Li S
Cell Death Dis; 2022 Sep; 13(9):808. PubMed ID: 36130940
[TBL] [Abstract][Full Text] [Related]
10. Dynamic Chromatin Targeting of BRD4 Stimulates Cardiac Fibroblast Activation.
Stratton MS; Bagchi RA; Felisbino MB; Hirsch RA; Smith HE; Riching AS; Enyart BY; Koch KA; Cavasin MA; Alexanian M; Song K; Qi J; Lemieux ME; Srivastava D; Lam MPY; Haldar SM; Lin CY; McKinsey TA
Circ Res; 2019 Sep; 125(7):662-677. PubMed ID: 31409188
[TBL] [Abstract][Full Text] [Related]
11. Polyunsaturated fatty acid biosynthesis pathway determines ferroptosis sensitivity in gastric cancer.
Lee JY; Nam M; Son HY; Hyun K; Jang SY; Kim JW; Kim MW; Jung Y; Jang E; Yoon SJ; Kim J; Kim J; Seo J; Min JK; Oh KJ; Han BS; Kim WK; Bae KH; Song J; Kim J; Huh YM; Hwang GS; Lee EW; Lee SC
Proc Natl Acad Sci U S A; 2020 Dec; 117(51):32433-32442. PubMed ID: 33288688
[TBL] [Abstract][Full Text] [Related]
12. Early-immediate gene Egr1 is associated with TGFβ1 regulation of epigenetic reader Bromodomain-containing protein 4 via the canonical Smad3 signaling in hepatic stellate cells in vitro and in vivo.
Tian H; Xu F; Zhao F; Pan N; Lu S; Jia X; Zhou Y
FASEB J; 2022 Nov; 36(11):e22605. PubMed ID: 36250963
[TBL] [Abstract][Full Text] [Related]
13. Targeting the BRD4-HOXB13 Coregulated Transcriptional Networks with Bromodomain-Kinase Inhibitors to Suppress Metastatic Castration-Resistant Prostate Cancer.
Nerlakanti N; Yao J; Nguyen DT; Patel AK; Eroshkin AM; Lawrence HR; Ayaz M; Kuenzi BM; Agarwal N; Chen Y; Gunawan S; Karim RM; Berndt N; Puskas J; Magliocco AM; Coppola D; Dhillon J; Zhang J; Shymalagovindarajan S; Rix U; Kim Y; Perera R; Lawrence NJ; Schonbrunn E; Mahajan K
Mol Cancer Ther; 2018 Dec; 17(12):2796-2810. PubMed ID: 30242092
[TBL] [Abstract][Full Text] [Related]
14. BRD4 regulates fructose-inducible lipid accumulation-related genes in the mouse liver.
Yamada A; Honma K; Mochizuki K; Goda T
Metabolism; 2016 Oct; 65(10):1478-88. PubMed ID: 27621183
[TBL] [Abstract][Full Text] [Related]
15. BRD4 localization to lineage-specific enhancers is associated with a distinct transcription factor repertoire.
Najafova Z; Tirado-Magallanes R; Subramaniam M; Hossan T; Schmidt G; Nagarajan S; Baumgart SJ; Mishra VK; Bedi U; Hesse E; Knapp S; Hawse JR; Johnsen SA
Nucleic Acids Res; 2017 Jan; 45(1):127-141. PubMed ID: 27651452
[TBL] [Abstract][Full Text] [Related]
16. Emerging roles of bromodomain protein 4 in regulation of stem cell identity.
Dey A; Uppal S; Giri J; Misra HS
Stem Cells; 2021 Dec; 39(12):1615-1624. PubMed ID: 34520583
[TBL] [Abstract][Full Text] [Related]
17. An integrated view of lipid metabolism in ferroptosis revisited via lipidomic analysis.
Kim JW; Lee JY; Oh M; Lee EW
Exp Mol Med; 2023 Aug; 55(8):1620-1631. PubMed ID: 37612411
[TBL] [Abstract][Full Text] [Related]
18. Epigenetic reader BRD4 supports mycobacterial pathogenesis by co-modulating host lipophagy and angiogenesis.
Mukherjee T; Bhatt B; Prakhar P; Lohia GK; Rajmani RS; Balaji KN
Autophagy; 2022 Feb; 18(2):391-408. PubMed ID: 34074211
[No Abstract] [Full Text] [Related]
19. Bromodomain-Containing Protein 4: A Druggable Target.
Shi Y; Liu J; Zhao Y; Cao J; Li Y; Guo F
Curr Drug Targets; 2019; 20(15):1517-1536. PubMed ID: 31215391
[TBL] [Abstract][Full Text] [Related]
20. Lipid metabolism alterations and ferroptosis in cancer: Paving the way for solving cancer resistance.
Lee J; Shin D; Roh JL
Eur J Pharmacol; 2023 Feb; 941():175497. PubMed ID: 36621602
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
